May 19, 2017
Derma Sciences Inc. shareholders on Friday agreed to drop a putative class action seeking to block Integra LifeSciences Holdings Corp.'s $204 million proposal to buy the tissue regeneration company, telling a New Jersey federal judge that supplemental regulatory disclosures have rendered the claims moot.
February 01, 2017
Integra LifeSciences Holdings Corp.'s proposal to buy Derma Sciences Inc. is unfair to shareholders because it undervalues the company and unfairly rewards Derma Sciences executives, according to proposed class actions filed in New Jersey and Delaware.